Price
$1.14
Increased by +1.33%
Dollar volume (20D)
170.65 K
ADR%
9.82
Earnings report date
May 12, 2025
Shares float
12.50 M
Shares short
2.07 M [16.55%]
Shares outstanding
49.88 M
Market cap
62.34 M
Beta
1.35
Price/earnings
N/A
20D range
1.02 1.38
50D range
1.01 1.80
200D range
1.01 3.42

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa.

The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow.

It also provides PhenoCycler and PhenoImager reagents; and biopharma services.

In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI.

Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Mar 3, 25 -0.17
Increased by +22.73%
-0.16
Decreased by -4.62%
Nov 14, 24 -0.18
Increased by +31.31%
-0.20
Increased by +10.70%
Aug 5, 24 -0.27
Increased by +41.30%
-0.27
May 13, 24 -0.48
Increased by +2.04%
-0.29
Decreased by -65.52%
Mar 4, 24 -0.22
Increased by +56.00%
-0.27
Increased by +18.52%
Nov 8, 23 -0.26
Increased by +44.68%
-0.37
Increased by +29.73%
Aug 7, 23 -0.46
Increased by +2.13%
-0.44
Decreased by -4.55%
May 8, 23 -0.49
Decreased by -11.36%
-0.48
Decreased by -2.08%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 21.34 M
Increased by +16.32%
-8.20 M
Increased by +65.09%
Decreased by -38.41%
Increased by +69.98%
Dec 31, 24 21.34 M
Decreased by -19.42%
-8.20 M
Increased by +24.10%
Decreased by -38.41%
Increased by +5.81%
Sep 30, 24 18.81 M
Decreased by -25.39%
-10.53 M
Increased by +18.45%
Decreased by -55.98%
Decreased by -9.30%
Jun 30, 24 23.16 M
Decreased by -1.52%
-13.15 M
Increased by +36.79%
Decreased by -56.76%
Increased by +35.82%
Mar 31, 24 18.35 M
Decreased by -14.29%
-23.48 M
Decreased by -24.90%
Decreased by -127.98%
Decreased by -45.73%
Dec 31, 23 26.49 M
Increased by +24.83%
-10.80 M
Increased by +42.77%
Decreased by -40.78%
Increased by +54.15%
Sep 30, 23 25.21 M
Increased by +33.75%
-12.92 M
Increased by +27.73%
Decreased by -51.22%
Increased by +45.97%
Jun 30, 23 23.52 M
Increased by +31.45%
-20.80 M
Decreased by -18.91%
Decreased by -88.44%
Increased by +9.54%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY